People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Study ID
NCT07621679
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
70 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Device: Heel2Toe[TM] sensor — DEVICE
    Heel2Toe is a new generation of wearables that provides real-time auditory feedback when the person takes a good step, one in which the step is initiated with a strong heel strike.
  • Technology-assisted therapeutic walking program — BEHAVIORAL
    Co-designed, evidence-based technology-assisted, therapeutic walking program developed by physiotherapy researchers, clinicians, and frail and non-frail seniors. It consists of training elements (derived through international consensus and endorsed by 600 older Canadians) for optimal gait pattern with the use of a biofeedback device, the Heel2Toe™ sensor, which is introduced to reinforce the gait optimizing training and encourage home practice.

Study Details

The aim of the Walk BEST study is to provide evidence that it is feasible to implement the technology assisted gait- focused walking program Walk-BEST™ in older adults with osteoporosis, and that this program is acceptable to this population.

Key Dates

Start date
May 7, 2026
Status verified
May 2026
Primary completion
May 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
28 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Walk-BEST Immediate
    Assigned to receive the Heel2Toe sensor and Walk BEST intervention right away.
  • Active Comparator: Walk-BEST Delayed
    Assigned to receive the Heel2Toe sensor and Walk BEST intervention after a delay of 3 months.

Primary Outcome Measure

Study recruitment rates (feasibility objective) [ Time Frame: 3 months ]

Central Contacts

Related Studies